RxDoctor Payments DataLook up a doctor →

William Lawler

Hematology & Oncology · Fullerton, CANPI 1700886702

Payments from drug & device makers

$5,744,898in general payments, 2019–2025

Across 866 payments — averaging $6633.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2.4M
  • Merck$1.1M
  • AstraZeneca$535K
  • Astrazeneca UK Limited$308K
  • Beigene, Ltd.$251K
  • Puma Biotechnology, Inc.$154K
  • plus $919K from 53 others
$1,988in research payments, 2019–2025

Across 2 payments — averaging $994.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$1K
  • Eli Lilly$580

What the payments were for

  • Food & beverage$5,51197%
  • Education$1613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,744,898 in reported general payments places this provider in the 95th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Other hematology & oncology in Fullerton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →